Founded in 1961, Agis started as a pharmaceutical importer in Israel and later expanded into drug development and production. Under the leadership of Mori Arkin, Agis became a major player in the dermatological generic space in the US. In 2005, the company was acquired by Perrigo in an $818M transaction. Arkin Holdings now focuses on empowering companies that create breakthrough healthcare technologies.